More about

Renin-Angiotensin System

News
December 01, 2020
1 min read
Save

Renin-angiotensin system inhibitors show more benefits in CKD vs calcium channel blockers

Patients with chronic kidney disease who were initiated on renin-angiotensin system inhibitors experienced greater benefits, including a reduced need for dialysis, than those initiated on calcium channel blockers.

News
October 06, 2020
3 min read
Save

Efficacy of vericiguat in HFrEF consistent across multiple guideline-recommended therapies

Efficacy of vericiguat in HFrEF consistent across multiple guideline-recommended therapies

An analysis of the VICTORIA trial showed that the benefits of vericiguat in HF with reduced ejection fraction was consistent across various background therapies for HFrEF, a speaker reported.

News
July 06, 2020
2 min read
Save

RAAS inhibitor use may reduce 3-year colorectal cancer risk in certain patients

RAAS inhibitor use may reduce 3-year colorectal cancer risk in certain patients

Use of renin-angiotensin-aldosterone system, or RAAS, antagonists such as ACE inhibitors or angiotensin receptor blockers was linked to reduced risk for colorectal cancer in the 3 years after an index colonoscopy with negative diagnosis.

News
May 26, 2020
1 min read
Save

Top in cardiology: RAAS antagonists, anticoagulation and COVID-19

Top in cardiology: RAAS antagonists, anticoagulation and COVID-19

Emerging data suggest that renin-angiotensin-aldosterone system, or RAAS, antagonists do not worsen outcomes of COVID-19, confirming recommendations released in March by various cardiology societies that patients who become infected with the coronavirus while receiving RAAS antagonists should continue to take them. This was the top story in cardiology last week.

News
April 23, 2020
3 min read
Save

Renin angiotensin system inhibition may not negatively affect patients with COVID-19

Renin angiotensin system inhibition may not negatively affect patients with COVID-19

ACE inhibitors and angiotensin II receptor antagonists did not affect the severity of or mortality from COVID-19 in patients with hypertension who were hospitalized for the disease, according to a brief report published in JAMA Cardiology.

News
October 13, 2019
3 min watch
Save

VIDEO: Potassium-binding agents help enable tolerance of HF medications

VIDEO: Potassium-binding agents help enable tolerance of HF medications

CHICAGO — In this video exclusive, Cardiology Today Editorial Board Member Ileana L. Piña, MD, MPH, discussed her Cardiometabolic Health Congress workshop on the role of potassium-binding agents in optimizing guideline-directed therapy for HF.

News
September 24, 2019
2 min read
Save

Post-chemotherapy neurohormonal therapies may improve ejection fraction

Post-chemotherapy neurohormonal therapies may improve ejection fraction

Neurohormonal therapies for the prevention of cardiotoxicity in patients who received chemotherapy conferred improvements in left ventricular ejection fraction as well as left ventricular strain, but benefits were minor and may be within inter-test variability of measurement, researchers reported.

News
September 04, 2019
2 min read
Save

Statins, antiplatelets, RAAS inhibitors tied to mortality benefit after CABG: SWEDEHEART

PARIS — New data from the SWEDEHEART registry presented at the European Society of Cardiology Congress show that use of statins, antiplatelet therapies and renin-angiotensin-aldosterone system inhibitors yields reduced risk for mortality after CABG.

News
September 03, 2019
3 min read
Save

CLARIFY: Angina in prior MI, stable CAD confers poor prognosis

PARIS — Among a cohort of patients with stable CAD, angina yielded worse outcomes in patients with prior MI but did not make a difference in patients without prior MI, according to results from the CLARIFY registry presented at the European Society of Cardiology Congress.

News
August 09, 2017
5 min read
Save

Patient-specific pharmacotherapy plan may reduce HF hospitalizations

Patient-specific pharmacotherapy plan may reduce HF hospitalizations

HF remains a complex clinical syndrome. It is estimated that nearly 6 million Americans have HF and more than 800,000 new cases of HF are diagnosed annually in the United States.

View more